Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended		9 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Mar. 31, 2015	Mar. 31, 2014
Revenue	$ 3,658	$ 4,448	$ 3,658	$ 4,448
Operating expenses:
General and administrative (including stock-based compensation (Note 9))	1,237,604	354,005	1,928,141	1,985,567
Depreciation	156,000	244,256	468,043	734,559
Research and development (including stock-based compensation (Note 9))	213,025	79,190	383,848	25,745
Total operating expenses	1,606,629	677,451	2,780,032	2,745,871
Loss from operations	(1,602,971)	(673,003)	(2,776,374)	(2,741,423)
Other expense:
Interest expense	77,740	100,285	275,043	275,002
Other expense				1,918
	77,740	100,285	275,043	276,920
Net loss	(1,680,711)	(773,288)	(3,051,417)	(3,018,343)
Net loss attributable to the noncontrolling interest	8,023	1,327	10,122	4,065
Net loss attributable to Bion	(1,672,688)	(771,961)	(3,041,295)	(3,014,278)
Dividends on preferred stock	(500)	(500)	(1,500)	(1,500)
Net loss applicable to Bion's common stockholders	$ (1,673,188)	$ (772,461)	$ (3,042,795)	$ (3,015,778)
Net loss applicable to Bion's common stockholders per basic and diluted common share (in Dollars per share)	$ (0.08)	$ (0.04)	$ (0.15)	$ (0.16)
Weighted-average number of common shares outstanding: Basic and diluted (in Shares)	20,835,885	18,783,957	20,090,740	18,412,042